BridgeAnticoag appThe BridgeAnticoag app supports clinicians across specialties in safely managing anticoagulation around an invasive procedure for NVAF patients. The app calculates patient and procedural risk to provide individualized advice that balances bleed and stroke risk.

Use the app to assess whether and how to:

  • Interrupt anticoagulation
  • Bridge anticoagulation
  • Restart anticoagulation

Email yourself a detailed report of the app assessment.

Advice from the app is derived from the 2016 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation. The information and recommendations in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.

Search “BridgeAnticoag” on the web or in your app store to download the app for free.

We want to hear from you!
Help the ACC find new and better ways to deliver guideline content to clinicians. Share your feedback:

Questions? Learn more about the App by reviewing a list of frequently asked questions below.

  What is the BridgeAnticoag App?
  What is the BridgeAnticoag App?

The BridgeAnticoag app supports clinicians across specialties in safely managing anticoagulation around an invasive procedure for NVAF patients. The app calculates patient and procedural risk to provide individualized advice that balances bleed and stroke risk.

Use the app to assess whether and how to:

  • Interrupt anticoagulation
  • Bridge anticoagulation
  • Restart anticoagulation

Email yourself a detailed report of the app assessment.

Advice from the app is derived from the 2016 ACC Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation. The information and recommendations in this app are meant to support clinical decision making. They are not meant to represent the only or best course of care, or replace clinical judgment. Therapeutic options should be determined after discussion between the patient and their care provider.

  How can I access the BridgeAnticoag App?
  How can I access the BridgeAnticoag App?

The BridgeAnticoag App is free for both ACC members and non-members.

  • To download on a mobile device (Apple or Android), search “BridgeAnticoag” in the iTunes or GooglePlay app stores.
  • The access on the web, go to: tools.acc.org/bridgeanticoag
  How is the BridgeAnticoag App intended to be used?
  How is the BridgeAnticoag App intended to be used?

This App is meant to support clinical decision making and planning regarding periprocedural management of anticoagulation in patients with nonvalvular AF. The app should be used by clinicians, in consult with appropriate specialists, to determine whether and when a patient’s anticoagulation should be interrupted, whether a how a patient should be bridged, and how to restart a patient’s anticoagulation once it is interrupted. Information in the App is intended to support clinical decision making and does not represent the only or the best course of care, or replace clinical judgment. Patients and their care provider should discuss therapeutic options.

  Where did the information and recommendations in the BridgeAnticoag App come from?
  Where did the information and recommendations in the BridgeAnticoag App come from?

The questions and advice in this app are derived from the algorithms that can be found in the ACC’s 2017 Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation document. The content of both the document and the resulting app was informed by input from a wide variety of specialists as a result of ACC’s Anticoagulation Consortium Roundtable series, a part of ACC’s Anticoagulation Initiative.

  How was the BridgeAnticoag App developed and tested?
  How was the BridgeAnticoag App developed and tested?

The App was developed by the ACC to transform cardiovascular care and improve heart health through the implementation of clinical policy at the point of care. It was developed with the review and guidance of a work group of ACC members who also served on the writing committee for the Expert Consensus Pathway document, and with initial oversight from ACC Best Practice and Quality Improvement Subcommittee. Development of the App included several rounds of user testing with members of the ACC and other clinicians from relevant specialties.

  Are there plans to further update the BridgeAnticoag App?
  Are there plans to further update the BridgeAnticoag App?

Content in the App will be updated to reflect any changes to its source document and the related clinical environment. Relevant relationships to other existing ACC clinical policy documents and resources will also be considered in future updates. Lastly, ongoing user feedback helps identify needs and opportunities for future updates.

  How can I provide feedback on the BridgeAnticoag App and how will it be used?
  How can I provide feedback on the BridgeAnticoag App and how will it be used?

You can provide feedback and suggestions about the App in two ways:

  1. Complete the ACC’s feedback survey here, which is also accessible through the “About the App” section in the App.
  2. Leave comments on the iTunes or Google Play page for the App.

The ACC is also collecting data about the App through analytics, usability studies, and impact studies when possible. Feedback is used to ensure the App’s accuracy and to identify opportunities for improving the App’s user experience and to inform the ACC Mobile App Framework.

  Who is the intended audience for the BridgeAnticoag App?
  Who is the intended audience for the BridgeAnticoag App?

The App’s intended target audience is clinicians involved in the anticoagulation management and periprocedural planning for nonvalvular AF patients. The app is purposefully designed to cover planned cardiac and non-cardiac procedures, and is intended to be used by clinicians both within and outside of cardiology.

  Will patients benefit from use of the BridgeAnticoag App?
  Will patients benefit from use of the BridgeAnticoag App?

The App is intended for use by clinicians as part of clinical practice. The App is freely available to all users, including patients, but is not intended for direct use by patients.

  Will any personal or patient information be collected from the BridgeAnticoag App?
  Will any personal or patient information be collected from the BridgeAnticoag App?

No patient information is collected and stored in the app. Anonymous user behavior (e.g., number of people who downloaded the app, how many times a day the app was used) will be gathered through Google Analytics. All data collected in the App is anonymous and cannot be traced back to an individual user.

  How does the BridgeAnticoag App relate to the other ACC tools, products, and programs?
  How does the BridgeAnticoag App relate to the other ACC tools, products, and programs?

The BridgeAnticoag App is a translation of ACC’s 2017 Expert Consensus Decision Pathway for Periprocedural Management of Anticoagulation in Patients with Nonvalvular Atrial Fibrillation document. The content of both the document and the resulting app were informed by input from a wide variety of specialists as a result of ACC’s Anticoagulation Roundtable series, a part of ACC’s Anticoagulation Initiative. The app in intended to be used in concert with ACC’s other anticoagulation and atrial fibrillation clinical policy and tools, including the 2014 Atrial Fibrillation Guideline, and the AnticoagEvaluator app. Lastly, the App is part of the ACC Clinical Mobile App Collection designed to be used “on the go” to help optimize patient care. More information about ACC’s Clinical App Collection can be found here.

  What is the relationship of the BridgeAnticoag App to other societies and organizations?
  What is the relationship of the BridgeAnticoag App to other societies and organizations?

The App was developed by, and is solely a product of, the American College of Cardiology. However, in the process of the developing the source document, several specialty societies contributed lists of procedures commonly performed by their specialists, and bleed risk associated with those procedures for the average patient. We are grateful for the contribution of these societies, whose names are referenced within the app in the section where these procedures apply. In addition, inclusion of procedural risk as assigned by varies each societies does not imply endorsement of the app by the society, nor does it necessarily reflect the official views of the ACC.

  Are there any plans to link outputs from the BridgeAnticoag App to electronic medical records (EMRs)?
  Are there any plans to link outputs from the BridgeAnticoag App to electronic medical records (EMRs)?

The App has an email function for users to send a summary of their individual app sessions to a recipient of their choice which can then be transferred into EMR notes. Users call also ultilize a query string functionality to export data points from their EMR to populate the app’s questions. However, there is not currently functionality to export results and output from the app back to the EMR.

  Where can I get help and support with using the BridgeAnticoag App?

App Screenshots

statin app

statin app

statin app

statin app